Court Hands Pfizer Mixed Results In Lipitor Battle
An appeals court handed Pfizer Inc. a mixed ruling Wednesday, affirming a lower court's decision that a patent covering Pfizer's blockbuster drug Lipitor was valid, but striking down a second Lipitor-related...To view the full article, register now.
Already a subscriber? Click here to view full article